Glimpse.
Dr. Josef
1 hr 20 min video
4 min read
ADHD and Autism: How Diagnoses Became Commercial Brands
You just saved 1 hr 16 min.
The big takeaway
Psychiatrist Dr. Sami Tamimi argues that ADHD and autism are not discoveries of biological disorders but evolving cultural constructs driven by subjective criteria, pharmaceutical interests, and societal pressure. The expansion of these diagnoses—from rare conditions to affecting millions—reflects not new neuroscience but changing definitions, lowered thresholds, and the rise of a 'mental health industrial complex.' Long-term outcomes for medicated patients are often worse, not better, and the real drivers of distress are societal: hyper-individualism, performance pressure, and the erosion of resilience through pharmaceutical shortcuts.
What ADHD Actually Is (and Isn't)
ADHD is not a biological discovery
ADHD has no identifiable brain abnormality, blood test, or scan that confirms it. It is a descriptive label based entirely on subjective behavioral criteria (words like 'often squirm'), not evidence of a neurological disorder. The diagnosis was never grounded in neuroscience; it emerged from changing cultural ideas about behavior.
The horizontal and vertical expansion of ADHD
ADHD began as a rare condition (hyperkinetic disorder, 0.5–2% prevalence) affecting hyperactive children with learning difficulties. Over decades, definitions loosened horizontally (milder cases included), then expanded vertically (into adults, then women via 'masking'). Each step widened the population without new scientific evidence.
1950s–1980s
Hyperkinetic disorder: rare, severe, 0.5–2% prevalence
1980s–1990s
ADD introduced; criteria loosened; learning difficulties no longer excluded
Mid-1990s
ADHD (combined type) expands; prevalence rises
Mid-2000s
Adult ADHD emerges; vertical expansion into new population
2010s–present
Masking concept introduced; fastest growth in adult women
ADHD expanded through definition changes, not biological discovery
Upside-down science: hypothesis accepted before evidence
Normal science assumes a hypothesis is false until proven true. ADHD reversed this: the claim that inattention equals a brain disorder was accepted as fact first, then critics were asked to disprove it. This is backwards. No empirical evidence—no brain scan, blood test, or autopsy finding—distinguishes ADHD from normal variation.
Why ADHD Diagnoses Exploded
Subjective criteria masquerading as objectivity
ADHD symptoms rely on vague language ('often squirms,' 'frequently loses things'). There is no unit of measurement—how many squirms equal 'often'? When subjective criteria are dressed in scientific language, they expand easily, especially during times of social distress and dissatisfaction.
The mental health industrial complex
ADHD has become a commercial brand, not a medical diagnosis. Around it: pharmaceuticals, therapies, books, apps, educational toys, research institutes, and expert assessments. The ecosystem is mostly well-intentioned but collectively profits from expanding distress and alienation. It functions as a barometer of societal suffering.
Hyper-individualism and performance pressure drive diagnoses
Western culture ties social value to individual achievement and appearance, not to existence or community contribution. This creates constant pressure to measure up, fueling shame and inadequacy. ADHD becomes a soothing explanation: 'It's not me; it's my brain.' Collectivist cultures, where value is relational, show no equivalent epidemic.
Incentives for diagnosis: extended test time and accommodations
At elite universities, 30–40% of freshmen claim disabilities for extended exam time. At Oxford, when 25% extra time was offered for ADHD, screening revealed 90% of students 'had ADHD'—despite no blood tests or brain scans. The diagnosis becomes unfair advantage, not medical need.
90%
Oxford students screened who received ADHD diagnosis when extra exam time was incentivized
Diagnosis rates spike when accommodations are available
The Real Drivers of Attention and Focus Problems
Social media and information overload, not brain defects
Society is highly stimulating and information-dense. Social media trains short attention spans. But ADHD criteria are contradictory: inability to focus is a symptom, yet hyperfocus is also a symptom. This suggests the problem is not lost focus capacity but societal overstimulation and performance anxiety.
Unaddressed root causes: trauma, nutrition, sleep, identity
Children struggle for many reasons: domestic violence, foster care instability, ultra-processed food (60% of US children's calories), poor sleep, lack of meaningful identity. A diagnosis of ADHD bypasses these. Instead of addressing trauma, nutrition, or purpose, the child is medicated, and root causes remain invisible.
Diagnosis prevents holistic problem-solving
Once labeled ADHD, the child is locked into a 'neuro-reductionist' pathway. Instead of exploring sleep, exercise, diet, family dynamics, or meaningful interests, the focus narrows to dopamine and medication. This circular logic—'You're impulsive because you have ADHD; you have ADHD because you're impulsive'—prevents real investigation.
Stimulant Medications: Short-Term Gain, Long-Term Harm
What stimulants actually are and do
Adderall and similar drugs are amphetamines—controlled substances chemically similar to speed or cocaine. They work by creating tunnel vision and heightened focus via dopamine release. This is a generic effect, not a correction of dopamine deficiency (which has never been found). The effect is seductive but temporary and comes with serious risks.
Long-term outcomes are worse, not better
Norwegian research (Mikkelsen) using natural experiments found that children diagnosed with ADHD in high-diagnosis regions had worse outcomes: higher school dropout, unemployment, and disability benefit rates. Irish and Australian cohort studies found diagnosed children had lower self-esteem, more mood problems, and worse self-efficacy than undiagnosed peers with identical behavioral ratings.
Short-term (1–14 months)
Grades improve, focus appears better
Long-term (3+ years)
Differences disappear; medication users shorter, lighter, sleep-deprived
MTA study: medication benefits fade; side effects persist
Physical side effects: height, weight, sleep disruption
Long-term stimulant use increases metabolic rate and suppresses appetite and sleep. The MTA study found medicated children became shorter and lighter by 3 years. Sleep disruption is common, often leading to additional sedative prescriptions. These effects are rarely discussed with families.
Tolerance and escalating doses
The brain's homeostatic mechanisms adapt to stimulants. Dopamine receptors downregulate. Doses must increase over time to maintain effect. This creates a cycle of escalation without improving long-term outcomes, while exposing the developing brain to increasingly high levels of a controlled substance.
Emotional stunting and delayed maturation
Stimulants suppress emotional intensity and variability. Children on long-term medication miss the natural process of learning to weather emotions, disagreements, and failure—the foundation of resilience. When weaned off in adulthood, they experience full emotional intensity for the first time, often at age 40, unprepared and terrified.
The cascade into polypharmacy
A child on stimulants becomes jittery; an antidepressant (SSRI) is added. The SSRI causes irritability or impulsivity; an antipsychotic is added. The child gains weight and develops metabolic issues. By age 15, the child has five diagnoses and four medications, none addressing root causes. The system has created a 'mental patient' who never needed to be one.
Autism: From Rare Neurological Condition to Identity Brand
Autism's original meaning: withdrawal from reality
Over 100 years ago, 'autism' described an autistic state of mind—aloneness, withdrawal into one's own bubble. In 1943, Leo Kanner used it to diagnose 11 children with moderate-to-severe learning difficulties, visible neurological compromise, often no language, and conditions like epilepsy. Classical autism was rare (0.01–0.04%) and clearly neurologically rooted.
Asperger's introduction and the spectrum concept
In the late 1970s, Hans Asperger's paper (translated from German) described four children without learning difficulties but considered antisocial. Asperger was a Nazi apologist involved in child euthanasia programs. His work introduced the idea of autism as a spectrum and as a set of traits (social difficulty, language oddity, repetitive interests). This was not a discovery; it was a redefinition.
Horizontal and vertical expansion of autism
Autism expanded horizontally (milder social awkwardness, narrow interests, no learning difficulty) and vertically (into adults, then women via 'masking'). The spectrum now spans from people requiring 24-hour care to billionaires like Elon Musk. This renders the diagnosis clinically useless: it tells you nothing specific about a person's actual needs.
1
Classical autism (1943–1960s)
Severe, 0.01–0.04%, learning difficulties, neurological signs
2
Asperger's introduction (1980s)
No learning difficulties, socially awkward, narrow interests
3
Spectrum concept (1990s–2000s)
Traits-based, includes high-functioning adults
4
Masking era (2010s–present)
Rapid growth in adult women; entire spectrum of human functioning
Autism expanded from rare neurological condition to universal identity
Masking: a normal skill reframed as a symptom
Masking (hiding traits in social contexts) is taught to all children: behave differently at home, school, or with strangers. This is social competence, not pathology. By calling it a symptom, the diagnosis migrates from males (who don't mask as much) to women (who do), expanding the population without new evidence.
Autism as identity brand in hyper-individualistic culture
Successful people now publicly identify as autistic (Elon Musk, etc.), making it a status symbol. In a culture where social value depends on branding yourself and standing out, autism becomes an explanation for why you don't fit the mold. It's attractive because it says: 'I'm not broken; I'm different.' But it's a description, not an explanation.
Risks of Autism Diagnosis and Self-Identification
Self-imposed limitation through labeling
Once you believe you have autism, you may unconsciously avoid challenges, assume you can't do certain things, and stop trying. Sociologists have long known labeling's power. A person told at university 'you won't be able to manage this' may internalize the limit and underperform, even without medication. The diagnosis itself becomes disempowering.
Gateway to psychiatric medication
Autism diagnosis often leads to SSRIs for anxiety, antipsychotics for irritability. An editorial in the British Medical Journal recommended antipsychotics for autism-related irritability; both cited studies showed weight gain and behavioral benefits that disappeared by 6 months due to tolerance. Yet the medication persists, creating iatrogenic harm.
Inward focus instead of systemic change
Framing social difficulty as a brain trait shifts focus inward ('I need to fix my brain') rather than outward ('Why does society demand constant performance and emotional labor?'). This serves the status quo: instead of questioning hyper-individualism and performance culture, the person pathologizes themselves.
Self-identification without medication can be neutral
If someone identifies as autistic, finds community, and doesn't pursue medication or medical intervention, there may be no harm. The danger emerges when the label becomes a gateway to psychiatric treatment or a self-imposed ceiling on capability.
The Broader Crisis: Pathologizing a Generation
Never-before-seen levels of youth pathologization
The current generation of young people is the most pathologized in history. Millions believe something is broken or dysregulated in their brains. This belief itself may become self-fulfilling, undermining resilience and the natural capacity to weather difficulty.
5%
US children currently taking ADHD medication
Widespread medication without long-term benefit evidence
Resilience cannot be taught; it must be discovered
Resilience develops only through experiencing and surviving adversity. Medications, therapy, and diagnoses that short-circuit emotional struggle rob people of the chance to discover their capacity to endure. By sedating or managing away distress, we disempower the next generation from developing psychological depth.
Growing up is hard; that's not a disorder
Adolescence involves intense emotions, struggle, and identity confusion. This is not pathology; it's being human. The current culture medicalizes normal developmental distress, teaching young people that their emotions are symptoms to be managed rather than experiences to be lived through.
Economic and cultural roots of the mental health crisis
The explosion in ADHD and autism diagnoses is not a discovery of hidden disorders but a reflection of societal distress: hyper-individualism, performance pressure, social media, economic precarity, and the erosion of community. These diagnoses are a barometer of cultural malaise, not a solution to it.
Worth quoting
"These are ideas being put forward. They are not evidence-based constructs."
— Dr. Sami Tamimi, at [10:11]
"A description cannot cause itself. It's the opposite of holistic."
— Dr. Sami Tamimi, at [35:15]
"Resilience is something you have to discover. You can only discover what you're able to withstand by having to go through it."
— Dr. Sami Tamimi, at [55:56]
Made with Glimpse by Wozart
glimpse.wozart.com/v/elld320g
Share this infographic
Read this infographic as text

ADHD and Autism: How Diagnoses Became Commercial Brands

Summary of the video “ADHD Isn’t What You’ve Been Told: Psychiatrist Explains” by Dr. Josef.

Psychiatrist Dr. Sami Tamimi argues that ADHD and autism are not discoveries of biological disorders but evolving cultural constructs driven by subjective criteria, pharmaceutical interests, and societal pressure. The expansion of these diagnoses—from rare conditions to affecting millions—reflects not new neuroscience but changing definitions, lowered thresholds, and the rise of a 'mental health industrial complex.' Long-term outcomes for medicated patients are often worse, not better, and the real drivers of distress are societal: hyper-individualism, performance pressure, and the erosion of resilience through pharmaceutical shortcuts.

What ADHD Actually Is (and Isn't)

ADHD is not a biological discovery

ADHD has no identifiable brain abnormality, blood test, or scan that confirms it. It is a descriptive label based entirely on subjective behavioral criteria (words like 'often squirm'), not evidence of a neurological disorder. The diagnosis was never grounded in neuroscience; it emerged from changing cultural ideas about behavior.

The horizontal and vertical expansion of ADHD

ADHD began as a rare condition (hyperkinetic disorder, 0.5–2% prevalence) affecting hyperactive children with learning difficulties. Over decades, definitions loosened horizontally (milder cases included), then expanded vertically (into adults, then women via 'masking'). Each step widened the population without new scientific evidence.

Upside-down science: hypothesis accepted before evidence

Normal science assumes a hypothesis is false until proven true. ADHD reversed this: the claim that inattention equals a brain disorder was accepted as fact first, then critics were asked to disprove it. This is backwards. No empirical evidence—no brain scan, blood test, or autopsy finding—distinguishes ADHD from normal variation.

Why ADHD Diagnoses Exploded

Subjective criteria masquerading as objectivity

ADHD symptoms rely on vague language ('often squirms,' 'frequently loses things'). There is no unit of measurement—how many squirms equal 'often'? When subjective criteria are dressed in scientific language, they expand easily, especially during times of social distress and dissatisfaction.

The mental health industrial complex

ADHD has become a commercial brand, not a medical diagnosis. Around it: pharmaceuticals, therapies, books, apps, educational toys, research institutes, and expert assessments. The ecosystem is mostly well-intentioned but collectively profits from expanding distress and alienation. It functions as a barometer of societal suffering.

Hyper-individualism and performance pressure drive diagnoses

Western culture ties social value to individual achievement and appearance, not to existence or community contribution. This creates constant pressure to measure up, fueling shame and inadequacy. ADHD becomes a soothing explanation: 'It's not me; it's my brain.' Collectivist cultures, where value is relational, show no equivalent epidemic.

Incentives for diagnosis: extended test time and accommodations

At elite universities, 30–40% of freshmen claim disabilities for extended exam time. At Oxford, when 25% extra time was offered for ADHD, screening revealed 90% of students 'had ADHD'—despite no blood tests or brain scans. The diagnosis becomes unfair advantage, not medical need.

The Real Drivers of Attention and Focus Problems

Social media and information overload, not brain defects

Society is highly stimulating and information-dense. Social media trains short attention spans. But ADHD criteria are contradictory: inability to focus is a symptom, yet hyperfocus is also a symptom. This suggests the problem is not lost focus capacity but societal overstimulation and performance anxiety.

Unaddressed root causes: trauma, nutrition, sleep, identity

Children struggle for many reasons: domestic violence, foster care instability, ultra-processed food (60% of US children's calories), poor sleep, lack of meaningful identity. A diagnosis of ADHD bypasses these. Instead of addressing trauma, nutrition, or purpose, the child is medicated, and root causes remain invisible.

Diagnosis prevents holistic problem-solving

Once labeled ADHD, the child is locked into a 'neuro-reductionist' pathway. Instead of exploring sleep, exercise, diet, family dynamics, or meaningful interests, the focus narrows to dopamine and medication. This circular logic—'You're impulsive because you have ADHD; you have ADHD because you're impulsive'—prevents real investigation.

Stimulant Medications: Short-Term Gain, Long-Term Harm

What stimulants actually are and do

Adderall and similar drugs are amphetamines—controlled substances chemically similar to speed or cocaine. They work by creating tunnel vision and heightened focus via dopamine release. This is a generic effect, not a correction of dopamine deficiency (which has never been found). The effect is seductive but temporary and comes with serious risks.

Long-term outcomes are worse, not better

Norwegian research (Mikkelsen) using natural experiments found that children diagnosed with ADHD in high-diagnosis regions had worse outcomes: higher school dropout, unemployment, and disability benefit rates. Irish and Australian cohort studies found diagnosed children had lower self-esteem, more mood problems, and worse self-efficacy than undiagnosed peers with identical behavioral ratings.

Physical side effects: height, weight, sleep disruption

Long-term stimulant use increases metabolic rate and suppresses appetite and sleep. The MTA study found medicated children became shorter and lighter by 3 years. Sleep disruption is common, often leading to additional sedative prescriptions. These effects are rarely discussed with families.

Tolerance and escalating doses

The brain's homeostatic mechanisms adapt to stimulants. Dopamine receptors downregulate. Doses must increase over time to maintain effect. This creates a cycle of escalation without improving long-term outcomes, while exposing the developing brain to increasingly high levels of a controlled substance.

Emotional stunting and delayed maturation

Stimulants suppress emotional intensity and variability. Children on long-term medication miss the natural process of learning to weather emotions, disagreements, and failure—the foundation of resilience. When weaned off in adulthood, they experience full emotional intensity for the first time, often at age 40, unprepared and terrified.

The cascade into polypharmacy

A child on stimulants becomes jittery; an antidepressant (SSRI) is added. The SSRI causes irritability or impulsivity; an antipsychotic is added. The child gains weight and develops metabolic issues. By age 15, the child has five diagnoses and four medications, none addressing root causes. The system has created a 'mental patient' who never needed to be one.

Autism: From Rare Neurological Condition to Identity Brand

Autism's original meaning: withdrawal from reality

Over 100 years ago, 'autism' described an autistic state of mind—aloneness, withdrawal into one's own bubble. In 1943, Leo Kanner used it to diagnose 11 children with moderate-to-severe learning difficulties, visible neurological compromise, often no language, and conditions like epilepsy. Classical autism was rare (0.01–0.04%) and clearly neurologically rooted.

Asperger's introduction and the spectrum concept

In the late 1970s, Hans Asperger's paper (translated from German) described four children without learning difficulties but considered antisocial. Asperger was a Nazi apologist involved in child euthanasia programs. His work introduced the idea of autism as a spectrum and as a set of traits (social difficulty, language oddity, repetitive interests). This was not a discovery; it was a redefinition.

Horizontal and vertical expansion of autism

Autism expanded horizontally (milder social awkwardness, narrow interests, no learning difficulty) and vertically (into adults, then women via 'masking'). The spectrum now spans from people requiring 24-hour care to billionaires like Elon Musk. This renders the diagnosis clinically useless: it tells you nothing specific about a person's actual needs.

Masking: a normal skill reframed as a symptom

Masking (hiding traits in social contexts) is taught to all children: behave differently at home, school, or with strangers. This is social competence, not pathology. By calling it a symptom, the diagnosis migrates from males (who don't mask as much) to women (who do), expanding the population without new evidence.

Autism as identity brand in hyper-individualistic culture

Successful people now publicly identify as autistic (Elon Musk, etc.), making it a status symbol. In a culture where social value depends on branding yourself and standing out, autism becomes an explanation for why you don't fit the mold. It's attractive because it says: 'I'm not broken; I'm different.' But it's a description, not an explanation.

Risks of Autism Diagnosis and Self-Identification

Self-imposed limitation through labeling

Once you believe you have autism, you may unconsciously avoid challenges, assume you can't do certain things, and stop trying. Sociologists have long known labeling's power. A person told at university 'you won't be able to manage this' may internalize the limit and underperform, even without medication. The diagnosis itself becomes disempowering.

Gateway to psychiatric medication

Autism diagnosis often leads to SSRIs for anxiety, antipsychotics for irritability. An editorial in the British Medical Journal recommended antipsychotics for autism-related irritability; both cited studies showed weight gain and behavioral benefits that disappeared by 6 months due to tolerance. Yet the medication persists, creating iatrogenic harm.

Inward focus instead of systemic change

Framing social difficulty as a brain trait shifts focus inward ('I need to fix my brain') rather than outward ('Why does society demand constant performance and emotional labor?'). This serves the status quo: instead of questioning hyper-individualism and performance culture, the person pathologizes themselves.

Self-identification without medication can be neutral

If someone identifies as autistic, finds community, and doesn't pursue medication or medical intervention, there may be no harm. The danger emerges when the label becomes a gateway to psychiatric treatment or a self-imposed ceiling on capability.

The Broader Crisis: Pathologizing a Generation

Never-before-seen levels of youth pathologization

The current generation of young people is the most pathologized in history. Millions believe something is broken or dysregulated in their brains. This belief itself may become self-fulfilling, undermining resilience and the natural capacity to weather difficulty.

Resilience cannot be taught; it must be discovered

Resilience develops only through experiencing and surviving adversity. Medications, therapy, and diagnoses that short-circuit emotional struggle rob people of the chance to discover their capacity to endure. By sedating or managing away distress, we disempower the next generation from developing psychological depth.

Growing up is hard; that's not a disorder

Adolescence involves intense emotions, struggle, and identity confusion. This is not pathology; it's being human. The current culture medicalizes normal developmental distress, teaching young people that their emotions are symptoms to be managed rather than experiences to be lived through.

Economic and cultural roots of the mental health crisis

The explosion in ADHD and autism diagnoses is not a discovery of hidden disorders but a reflection of societal distress: hyper-individualism, performance pressure, social media, economic precarity, and the erosion of community. These diagnoses are a barometer of cultural malaise, not a solution to it.

Notable quotes

These are ideas being put forward. They are not evidence-based constructs. — Dr. Sami Tamimi
A description cannot cause itself. It's the opposite of holistic. — Dr. Sami Tamimi
Resilience is something you have to discover. You can only discover what you're able to withstand by having to go through it. — Dr. Sami Tamimi

More like this